Pure Global

Liquid Biopsy-based Early Detection of Ovarian Cancer: a Proof-of-concept Study ( PROFOUND-OC ) - Trial NCT06249308

Access comprehensive clinical trial information for NCT06249308 through Pure Global AI's free database. This phase not specified trial is sponsored by Fudan University and is currently Recruiting. The study focuses on Ovarian Cancer. Target enrollment is 168 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06249308
Recruiting
other
Trial Details
ClinicalTrials.gov • NCT06249308
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Liquid Biopsy-based Early Detection of Ovarian Cancer: a Proof-of-concept Study ( PROFOUND-OC )
A Multi-center, Perspective, Observational Case-control Study to Develop and Validate an Ovarian Cancer Early Detection Model Based on Peripheral Blood Multi-omic Analysis and Machine Learning

Study Focus

Ovarian Cancer

Blood collection

Observational

other

Sponsor & Location

Fudan University

Guangzhou,Shenyang,Shanghai, China

Timeline & Enrollment

N/A

Dec 18, 2023

Dec 31, 2026

168 participants

Primary Outcome

The performance of cfDNA methylation-based model for discriminating ovarian cancer versus non-cancer.

Summary

This study is a multi-center, observational study aiming at developing a machine
 learning-based early detection model using prospectively collected liquid biopsy samples from
 newly diagnosed ovarian cancer.

ICD-10 Classifications

Malignant neoplasm of ovary
Secondary malignant neoplasm of ovary
Benign neoplasm of ovary
Ovarian pregnancy
Ovarian dysfunction

Data Source

ClinicalTrials.gov

NCT06249308

Non-Device Trial